Rocket Pharmaceuticals Inc (RCKT) Annual Balance Sheets

Annual · GAAP · USD millions
Access RCKT quarterly Balance Sheets →
Reviewing balance sheet figures over time helps illustrate how Rocket Pharmaceuticals Inc manages its resources, obligations, and shareholder equity.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent77.56
Short-term Investments, Total111.37
Cash & Short-term Investments188.00
Prepaid Expense And Other Assets Current3.81
Total Current Assets192.73
Equipment/Property/Plant Net28.17
Goodwill net39.15
Intangible Assets25.15
Long-term investments0.00
Deposits Assets, Noncurrent AS0.48
Other Assets, Noncurrent44.76
Restricted Cash Equivalents Noncurrent1.34
Operating Lease Right Of Use Asset3.21
Total Assets330.45
Liabilities
Accounts Payable and Accrued Liabilities, Current LI27.29
Other Liabilities, Current2.92
Total Current Liabilities30.21
Total Long-term Debt0.00
Other liabilities, Noncurrent23.02
Operating Lease Liability Current1.00
Operating Lease Liability Noncurrent2.60
Total Liabilities53.23
Stockholders' Equity
Common Stock Value1.08
Treasury Stock Value0.00
Additional Paid In Capital Common Stock1,717.41
Retained Earnings / Accumulated Deficit-1,441.24
Other Equity-0.03
Common Stockholder's Equity277.22
Total Stockholder's Equity277.22
Liabilities & Stockholder's Equity330.45
4 historic quarters locked

Sign in to unlock the full Rocket Pharmaceuticals Inc balance sheet history.

About Rocket Pharmaceuticals Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: February 26, 2026
  • Source: rckt-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001193125-26-076551

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License